Olorinab (APD371), a peripherally restricted, highly selective, full agonist of the cannabinoid receptor type 2 (CB2), reduces visceral hypersensitivity in animal models

被引：0
|
作者：
Castro, J. [1 ]
Maddern, J. [1 ]
Garcia-Caraballo, S. [1 ]
Lumsden, A. [1 ]
Lindstrom, B. [2 ]
Adams, J. [2 ]
Brierley, S. M. [1 ]
机构：
[1] Flinders Univ S Australia, Visceral Pain Res Grp, SAHMRI, Adelaide, SA, Australia
[2] Arena Pharmaceut Inc, San Diego, CA USA
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2019年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
15
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates
    Gonsiorek, W.
    Lunn, C. A.
    Fan, X.
    Deno, G.
    Kozlowski, J.
    Hipkin, R. W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (08) : 1262 - 1271
  • [22] SYNTHETIC PERIPHERALLY RESTRICTED CANNABINOID SUPRESSES VOLUNTARY ALCOHOL INTAKE IN RATS VIA NON-CB1/CB2 RECEPTOR ACTION
    Marty, V. N.
    Mulpuri, Y.
    Munier, J. J.
    Lele, S.
    Vo, R. H.
    Yenokian, I.
    Liao, A.
    Spigelman, I.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 36A - 36A
  • [23] The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB2 receptor activation
    Reck, Antonio Matt
    Siderovski, David P.
    Kinsey, Steven G.
    NEUROPHARMACOLOGY, 2025, 264
  • [24] Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB2 receptor ligands
    Aly, Mayar W.
    Ludwig, Friedrich-Alexander
    Deuther-Conrad, Winnie
    Brust, Peter
    Abadi, Ashraf H.
    Moldovan, Rares-Petru
    Osman, Noha A.
    BIOORGANIC CHEMISTRY, 2021, 114
  • [25] Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5
    Tang, Yaliang
    Wolk, Barbara
    Britch, Stevie C.
    Craft, Rebecca M.
    Kendall, Debra A.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2021, 145 (04) : 319 - 326
  • [26] In vitro and in vivo characterization of A-796260:: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
    Yao, B. B.
    Hsieh, G. C.
    Frost, J. M.
    Fan, Y.
    Garrison, T. R.
    Daza, A. V.
    Grayson, G. K.
    Zhu, C. Z.
    Pai, M.
    Chandran, P.
    Salyers, A. K.
    Wensink, E. J.
    Honore, P.
    Sullivan, J. P.
    Dart, M. J.
    Meyer, M. D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 390 - 401
  • [27] Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease
    Jayant, Shalini
    Sharma, Brij Mohan
    Bansal, Rani
    Sharma, Bhupesh
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2016, 140 : 39 - 50
  • [28] In vitro and in vivo characterization of an orally-active Cannabinoid receptor 2 (CB2)-selective agonist, M68400
    Masubuchi, Kazuhiro
    Kato, Yutaka
    Sogawa, Yoshitaka
    Okano, Akihiro
    Yumiya, Yasunobu
    Naba, Hiroyasu
    Muramatsu, Hiroyuki
    Nishiyama, Yuuichi
    Haruyama, Toshio
    Yamasaki, Fumiaki
    Furusako, Shoji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 247P - 247P
  • [29] A CB2 cannabinoid receptor agonist attenuates the viscero-visceral hyper-reflexia associated with a rat model of persistent visceral pain
    Jaggar, SI
    Rice, ASC
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 507P : 18P - 19P
  • [30] Cannabinoid CB2 receptor agonist reduces local and systemic inflammation associated with pneumonia-induced sepsis in mice
    Souza, Camila Fernandes
    Borges, Luana Bolsoni
    Oliveira, Filipe Rodolfo Moreira Borges
    Silva, Priscila Creppas de Souza
    Patricio, Daniel Oliveira
    Rosales, Thiele Osvaldt
    Souza, Nicoly Fernandes
    Spiller, Fernando
    Mansur, Daniel Santos
    Assreuy, Jamil
    Sordi, Regina
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 959
12345